nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—leg—multiple sclerosis	0.175	0.521	CbGeAlD
Amifostine—ALPL—medulla oblongata—multiple sclerosis	0.0321	0.0957	CbGeAlD
Amifostine—ALPL—midbrain—multiple sclerosis	0.0294	0.0874	CbGeAlD
Amifostine—ALPL—cerebellum—multiple sclerosis	0.0227	0.0676	CbGeAlD
Amifostine—ALPPL2—nervous system—multiple sclerosis	0.0214	0.0636	CbGeAlD
Amifostine—ALPPL2—central nervous system—multiple sclerosis	0.0206	0.0613	CbGeAlD
Amifostine—ALPL—brain—multiple sclerosis	0.0184	0.0549	CbGeAlD
Amifostine—ALPPL2—brain—multiple sclerosis	0.0163	0.0486	CbGeAlD
Amifostine—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00466	0.0077	CcSEcCtD
Amifostine—Erythema multiforme—Cladribine—multiple sclerosis	0.00449	0.00742	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00426	0.00704	CcSEcCtD
Amifostine—Chills—Cladribine—multiple sclerosis	0.00426	0.00704	CcSEcCtD
Amifostine—Hiccups—Betamethasone—multiple sclerosis	0.00425	0.00703	CcSEcCtD
Amifostine—Hiccups—Dexamethasone—multiple sclerosis	0.00425	0.00703	CcSEcCtD
Amifostine—Arrhythmia—Cladribine—multiple sclerosis	0.00424	0.00701	CcSEcCtD
Amifostine—ENPP1—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00421	0.105	CbGdCrCtD
Amifostine—ENPP1—Betamethasone—Methylprednisolone—multiple sclerosis	0.00421	0.105	CbGdCrCtD
Amifostine—Pruritus—Fingolimod—multiple sclerosis	0.00421	0.00696	CcSEcCtD
Amifostine—ENPP1—Betamethasone—Dexamethasone—multiple sclerosis	0.00414	0.104	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Betamethasone—multiple sclerosis	0.00414	0.104	CbGdCrCtD
Amifostine—ENPP1—Betamethasone—Triamcinolone—multiple sclerosis	0.00405	0.101	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Triamcinolone—multiple sclerosis	0.00405	0.101	CbGdCrCtD
Amifostine—Dizziness—Fingolimod—multiple sclerosis	0.00393	0.0065	CcSEcCtD
Amifostine—ENPP1—Betamethasone—Prednisone—multiple sclerosis	0.00384	0.0961	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Prednisone—multiple sclerosis	0.00384	0.0961	CbGdCrCtD
Amifostine—Ill-defined disorder—Cladribine—multiple sclerosis	0.00383	0.00634	CcSEcCtD
Amifostine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.00382	0.00632	CcSEcCtD
Amifostine—ENPP1—Dexamethasone—Prednisolone—multiple sclerosis	0.00375	0.0938	CbGdCrCtD
Amifostine—ENPP1—Betamethasone—Prednisolone—multiple sclerosis	0.00375	0.0938	CbGdCrCtD
Amifostine—Malaise—Cladribine—multiple sclerosis	0.00373	0.00616	CcSEcCtD
Amifostine—Hiccups—Prednisone—multiple sclerosis	0.0037	0.00612	CcSEcCtD
Amifostine—Apnoea—Methotrexate—multiple sclerosis	0.00365	0.00603	CcSEcCtD
Amifostine—Erythema multiforme—Azathioprine—multiple sclerosis	0.00365	0.00603	CcSEcCtD
Amifostine—Cardiac arrest—Prednisolone—multiple sclerosis	0.00352	0.00581	CcSEcCtD
Amifostine—Chest pain—Cladribine—multiple sclerosis	0.00352	0.00581	CcSEcCtD
Amifostine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00351	0.00581	CcSEcCtD
Amifostine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00351	0.0058	CcSEcCtD
Amifostine—Discomfort—Cladribine—multiple sclerosis	0.00347	0.00574	CcSEcCtD
Amifostine—Chills—Azathioprine—multiple sclerosis	0.00346	0.00572	CcSEcCtD
Amifostine—Arrhythmia—Azathioprine—multiple sclerosis	0.00345	0.0057	CcSEcCtD
Amifostine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.00343	0.00566	CcSEcCtD
Amifostine—Renal failure—Mitoxantrone—multiple sclerosis	0.00342	0.00565	CcSEcCtD
Amifostine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00341	0.00563	CcSEcCtD
Amifostine—Tachycardia—Cladribine—multiple sclerosis	0.00329	0.00544	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—KCNA3—multiple sclerosis	0.00328	0.169	CbGpPWpGaD
Amifostine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00323	0.00535	CcSEcCtD
Amifostine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00323	0.00534	CcSEcCtD
Amifostine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00319	0.00527	CcSEcCtD
Amifostine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00319	0.00527	CcSEcCtD
Amifostine—Bradycardia—Mitoxantrone—multiple sclerosis	0.00318	0.00525	CcSEcCtD
Amifostine—Hypotension—Cladribine—multiple sclerosis	0.00315	0.00521	CcSEcCtD
Amifostine—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00312	0.00515	CcSEcCtD
Amifostine—Malaise—Azathioprine—multiple sclerosis	0.00303	0.00501	CcSEcCtD
Amifostine—Dyspnoea—Cladribine—multiple sclerosis	0.00301	0.00497	CcSEcCtD
Amifostine—Somnolence—Cladribine—multiple sclerosis	0.003	0.00495	CcSEcCtD
Amifostine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00294	0.00485	CcSEcCtD
Amifostine—Cardiac arrest—Betamethasone—multiple sclerosis	0.00294	0.00485	CcSEcCtD
Amifostine—Discomfort—Azathioprine—multiple sclerosis	0.00283	0.00467	CcSEcCtD
Amifostine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00281	0.00465	CcSEcCtD
Amifostine—Chills—Mitoxantrone—multiple sclerosis	0.0028	0.00463	CcSEcCtD
Amifostine—Myocardial infarction—Prednisolone—multiple sclerosis	0.00279	0.00462	CcSEcCtD
Amifostine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00279	0.00461	CcSEcCtD
Amifostine—Feeling abnormal—Cladribine—multiple sclerosis	0.00278	0.00459	CcSEcCtD
Amifostine—Urticaria—Cladribine—multiple sclerosis	0.00268	0.00443	CcSEcCtD
Amifostine—Body temperature increased—Cladribine—multiple sclerosis	0.00267	0.00441	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—LINGO1—multiple sclerosis	0.00262	0.135	CbGpPWpGaD
Amifostine—Bradycardia—Prednisolone—multiple sclerosis	0.00261	0.00431	CcSEcCtD
Amifostine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00258	0.00427	CcSEcCtD
Amifostine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00258	0.00426	CcSEcCtD
Amifostine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00257	0.00425	CcSEcCtD
Amifostine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00256	0.00424	CcSEcCtD
Amifostine—Hypotension—Azathioprine—multiple sclerosis	0.00256	0.00423	CcSEcCtD
Amifostine—Cardiac arrest—Prednisone—multiple sclerosis	0.00256	0.00423	CcSEcCtD
Amifostine—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00252	0.00416	CcSEcCtD
Amifostine—Hypersensitivity—Cladribine—multiple sclerosis	0.00248	0.00411	CcSEcCtD
Amifostine—Malaise—Mitoxantrone—multiple sclerosis	0.00245	0.00405	CcSEcCtD
Amifostine—Bradycardia—Triamcinolone—multiple sclerosis	0.0024	0.00396	CcSEcCtD
Amifostine—Bradycardia—Methylprednisolone—multiple sclerosis	0.00239	0.00395	CcSEcCtD
Amifostine—Pruritus—Cladribine—multiple sclerosis	0.00239	0.00394	CcSEcCtD
Amifostine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.00238	0.00394	CcSEcCtD
Amifostine—Convulsion—Mitoxantrone—multiple sclerosis	0.00235	0.00389	CcSEcCtD
Amifostine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00234	0.00388	CcSEcCtD
Amifostine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00234	0.00388	CcSEcCtD
Amifostine—Hypertension—Mitoxantrone—multiple sclerosis	0.00234	0.00388	CcSEcCtD
Amifostine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00233	0.00385	CcSEcCtD
Amifostine—Myocardial infarction—Betamethasone—multiple sclerosis	0.00233	0.00385	CcSEcCtD
Amifostine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.00232	0.00384	CcSEcCtD
Amifostine—Chest pain—Mitoxantrone—multiple sclerosis	0.00231	0.00382	CcSEcCtD
Amifostine—Arrhythmia—Prednisolone—multiple sclerosis	0.00229	0.00378	CcSEcCtD
Amifostine—Discomfort—Mitoxantrone—multiple sclerosis	0.00228	0.00378	CcSEcCtD
Amifostine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00226	0.00373	CcSEcCtD
Amifostine—Dizziness—Cladribine—multiple sclerosis	0.00223	0.00369	CcSEcCtD
Amifostine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00222	0.00366	CcSEcCtD
Amifostine—Shock—Mitoxantrone—multiple sclerosis	0.00218	0.0036	CcSEcCtD
Amifostine—Bradycardia—Betamethasone—multiple sclerosis	0.00217	0.00359	CcSEcCtD
Amifostine—Bradycardia—Dexamethasone—multiple sclerosis	0.00217	0.00359	CcSEcCtD
Amifostine—Body temperature increased—Azathioprine—multiple sclerosis	0.00217	0.00358	CcSEcCtD
Amifostine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00216	0.00358	CcSEcCtD
Amifostine—Vomiting—Cladribine—multiple sclerosis	0.00214	0.00354	CcSEcCtD
Amifostine—Rash—Cladribine—multiple sclerosis	0.00213	0.00351	CcSEcCtD
Amifostine—Dermatitis—Cladribine—multiple sclerosis	0.00212	0.00351	CcSEcCtD
Amifostine—Arrhythmia—Triamcinolone—multiple sclerosis	0.0021	0.00348	CcSEcCtD
Amifostine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.0021	0.00347	CcSEcCtD
Amifostine—Hypotension—Mitoxantrone—multiple sclerosis	0.00207	0.00342	CcSEcCtD
Amifostine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00207	0.00342	CcSEcCtD
Amifostine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00204	0.00338	CcSEcCtD
Amifostine—Myocardial infarction—Prednisone—multiple sclerosis	0.00203	0.00336	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00202	0.00334	CcSEcCtD
Amifostine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00202	0.00334	CcSEcCtD
Amifostine—Malaise—Prednisolone—multiple sclerosis	0.00201	0.00332	CcSEcCtD
Amifostine—Nausea—Cladribine—multiple sclerosis	0.002	0.00331	CcSEcCtD
Amifostine—Syncope—Prednisolone—multiple sclerosis	0.002	0.0033	CcSEcCtD
Amifostine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00198	0.00327	CcSEcCtD
Amifostine—Somnolence—Mitoxantrone—multiple sclerosis	0.00197	0.00326	CcSEcCtD
Amifostine—Loss of consciousness—Prednisolone—multiple sclerosis	0.00196	0.00324	CcSEcCtD
Amifostine—Convulsion—Prednisolone—multiple sclerosis	0.00193	0.00319	CcSEcCtD
Amifostine—Hypertension—Prednisolone—multiple sclerosis	0.00192	0.00318	CcSEcCtD
Amifostine—Arrhythmia—Dexamethasone—multiple sclerosis	0.00191	0.00315	CcSEcCtD
Amifostine—Arrhythmia—Betamethasone—multiple sclerosis	0.00191	0.00315	CcSEcCtD
Amifostine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.0019	0.00314	CcSEcCtD
Amifostine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.0019	0.00314	CcSEcCtD
Amifostine—Bradycardia—Prednisone—multiple sclerosis	0.00189	0.00313	CcSEcCtD
Amifostine—Discomfort—Prednisolone—multiple sclerosis	0.00187	0.0031	CcSEcCtD
Amifostine—Malaise—Triamcinolone—multiple sclerosis	0.00185	0.00305	CcSEcCtD
Amifostine—Malaise—Methylprednisolone—multiple sclerosis	0.00184	0.00305	CcSEcCtD
Amifostine—Syncope—Triamcinolone—multiple sclerosis	0.00184	0.00304	CcSEcCtD
Amifostine—Syncope—Methylprednisolone—multiple sclerosis	0.00183	0.00303	CcSEcCtD
Amifostine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00183	0.00302	CcSEcCtD
Amifostine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00182	0.00301	CcSEcCtD
Amifostine—Dizziness—Azathioprine—multiple sclerosis	0.00181	0.003	CcSEcCtD
Amifostine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.0018	0.00298	CcSEcCtD
Amifostine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.0018	0.00297	CcSEcCtD
Amifostine—Shock—Prednisolone—multiple sclerosis	0.00179	0.00296	CcSEcCtD
Amifostine—Convulsion—Triamcinolone—multiple sclerosis	0.00178	0.00293	CcSEcCtD
Amifostine—Tachycardia—Prednisolone—multiple sclerosis	0.00177	0.00293	CcSEcCtD
Amifostine—Convulsion—Methylprednisolone—multiple sclerosis	0.00177	0.00293	CcSEcCtD
Amifostine—Hypertension—Triamcinolone—multiple sclerosis	0.00177	0.00292	CcSEcCtD
Amifostine—Hypertension—Methylprednisolone—multiple sclerosis	0.00176	0.00292	CcSEcCtD
Amifostine—Urticaria—Mitoxantrone—multiple sclerosis	0.00176	0.00291	CcSEcCtD
Amifostine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00175	0.0029	CcSEcCtD
Amifostine—Vomiting—Azathioprine—multiple sclerosis	0.00174	0.00288	CcSEcCtD
Amifostine—Rash—Azathioprine—multiple sclerosis	0.00173	0.00286	CcSEcCtD
Amifostine—Dermatitis—Azathioprine—multiple sclerosis	0.00173	0.00285	CcSEcCtD
Amifostine—Flushing—Prednisone—multiple sclerosis	0.00173	0.00285	CcSEcCtD
Amifostine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00172	0.00285	CcSEcCtD
Amifostine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00172	0.00285	CcSEcCtD
Amifostine—Discomfort—Triamcinolone—multiple sclerosis	0.00172	0.00285	CcSEcCtD
Amifostine—Discomfort—Methylprednisolone—multiple sclerosis	0.00172	0.00284	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00172	0.00284	CcSEcCtD
Amifostine—Renal failure—Methotrexate—multiple sclerosis	0.0017	0.00281	CcSEcCtD
Amifostine—Malaise—Betamethasone—multiple sclerosis	0.00168	0.00277	CcSEcCtD
Amifostine—Malaise—Dexamethasone—multiple sclerosis	0.00168	0.00277	CcSEcCtD
Amifostine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00167	0.00276	CcSEcCtD
Amifostine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00167	0.00276	CcSEcCtD
Amifostine—Syncope—Betamethasone—multiple sclerosis	0.00167	0.00276	CcSEcCtD
Amifostine—Syncope—Dexamethasone—multiple sclerosis	0.00167	0.00276	CcSEcCtD
Amifostine—Arrhythmia—Prednisone—multiple sclerosis	0.00166	0.00275	CcSEcCtD
Amifostine—Shock—Triamcinolone—multiple sclerosis	0.00164	0.00272	CcSEcCtD
Amifostine—Shock—Methylprednisolone—multiple sclerosis	0.00164	0.00271	CcSEcCtD
Amifostine—Loss of consciousness—Betamethasone—multiple sclerosis	0.00163	0.0027	CcSEcCtD
Amifostine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00163	0.0027	CcSEcCtD
Amifostine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00163	0.0027	CcSEcCtD
Amifostine—Tachycardia—Triamcinolone—multiple sclerosis	0.00163	0.0027	CcSEcCtD
Amifostine—Nausea—Azathioprine—multiple sclerosis	0.00163	0.00269	CcSEcCtD
Amifostine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00163	0.00269	CcSEcCtD
Amifostine—Convulsion—Dexamethasone—multiple sclerosis	0.00161	0.00266	CcSEcCtD
Amifostine—Convulsion—Betamethasone—multiple sclerosis	0.00161	0.00266	CcSEcCtD
Amifostine—Hypertension—Dexamethasone—multiple sclerosis	0.0016	0.00265	CcSEcCtD
Amifostine—Hypertension—Betamethasone—multiple sclerosis	0.0016	0.00265	CcSEcCtD
Amifostine—Discomfort—Dexamethasone—multiple sclerosis	0.00156	0.00258	CcSEcCtD
Amifostine—Discomfort—Betamethasone—multiple sclerosis	0.00156	0.00258	CcSEcCtD
Amifostine—Hypotension—Methylprednisolone—multiple sclerosis	0.00156	0.00258	CcSEcCtD
Amifostine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00152	0.00251	CcSEcCtD
Amifostine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00152	0.00251	CcSEcCtD
Amifostine—Ill-defined disorder—Prednisone—multiple sclerosis	0.0015	0.00248	CcSEcCtD
Amifostine—Feeling abnormal—Prednisolone—multiple sclerosis	0.0015	0.00248	CcSEcCtD
Amifostine—Shock—Dexamethasone—multiple sclerosis	0.00149	0.00247	CcSEcCtD
Amifostine—Shock—Betamethasone—multiple sclerosis	0.00149	0.00247	CcSEcCtD
Amifostine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00149	0.00246	CcSEcCtD
Amifostine—Tachycardia—Betamethasone—multiple sclerosis	0.00148	0.00245	CcSEcCtD
Amifostine—Tachycardia—Dexamethasone—multiple sclerosis	0.00148	0.00245	CcSEcCtD
Amifostine—Erythema multiforme—Methotrexate—multiple sclerosis	0.00147	0.00243	CcSEcCtD
Amifostine—Malaise—Prednisone—multiple sclerosis	0.00146	0.00241	CcSEcCtD
Amifostine—Syncope—Prednisone—multiple sclerosis	0.00145	0.0024	CcSEcCtD
Amifostine—Urticaria—Prednisolone—multiple sclerosis	0.00144	0.00239	CcSEcCtD
Amifostine—Loss of consciousness—Prednisone—multiple sclerosis	0.00142	0.00235	CcSEcCtD
Amifostine—Hypotension—Betamethasone—multiple sclerosis	0.00142	0.00234	CcSEcCtD
Amifostine—Hypotension—Dexamethasone—multiple sclerosis	0.00142	0.00234	CcSEcCtD
Amifostine—Vomiting—Mitoxantrone—multiple sclerosis	0.00141	0.00233	CcSEcCtD
Amifostine—Convulsion—Prednisone—multiple sclerosis	0.0014	0.00232	CcSEcCtD
Amifostine—Hypertension—Prednisone—multiple sclerosis	0.0014	0.00231	CcSEcCtD
Amifostine—Rash—Mitoxantrone—multiple sclerosis	0.0014	0.00231	CcSEcCtD
Amifostine—Dermatitis—Mitoxantrone—multiple sclerosis	0.0014	0.00231	CcSEcCtD
Amifostine—Chills—Methotrexate—multiple sclerosis	0.00139	0.00231	CcSEcCtD
Amifostine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00138	0.00228	CcSEcCtD
Amifostine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00137	0.00227	CcSEcCtD
Amifostine—Discomfort—Prednisone—multiple sclerosis	0.00136	0.00225	CcSEcCtD
Amifostine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00134	0.00221	CcSEcCtD
Amifostine—Urticaria—Triamcinolone—multiple sclerosis	0.00133	0.0022	CcSEcCtD
Amifostine—Urticaria—Methylprednisolone—multiple sclerosis	0.00133	0.00219	CcSEcCtD
Amifostine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00132	0.00218	CcSEcCtD
Amifostine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00132	0.00218	CcSEcCtD
Amifostine—Nausea—Mitoxantrone—multiple sclerosis	0.00132	0.00218	CcSEcCtD
Amifostine—Shock—Prednisone—multiple sclerosis	0.0013	0.00215	CcSEcCtD
Amifostine—Tachycardia—Prednisone—multiple sclerosis	0.00129	0.00213	CcSEcCtD
Amifostine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00126	0.00207	CcSEcCtD
Amifostine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00125	0.00207	CcSEcCtD
Amifostine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00125	0.00207	CcSEcCtD
Amifostine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00123	0.00204	CcSEcCtD
Amifostine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00123	0.00203	CcSEcCtD
Amifostine—Malaise—Methotrexate—multiple sclerosis	0.00122	0.00202	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—CBLB—multiple sclerosis	0.00121	0.0626	CbGpPWpGaD
Amifostine—Urticaria—Betamethasone—multiple sclerosis	0.00121	0.00199	CcSEcCtD
Amifostine—Urticaria—Dexamethasone—multiple sclerosis	0.00121	0.00199	CcSEcCtD
Amifostine—Dizziness—Prednisolone—multiple sclerosis	0.0012	0.00199	CcSEcCtD
Amifostine—Body temperature increased—Dexamethasone—multiple sclerosis	0.0012	0.00198	CcSEcCtD
Amifostine—Body temperature increased—Betamethasone—multiple sclerosis	0.0012	0.00198	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—SPP1—multiple sclerosis	0.0012	0.0618	CbGpPWpGaD
Amifostine—Pruritus—Triamcinolone—multiple sclerosis	0.00118	0.00196	CcSEcCtD
Amifostine—Pruritus—Methylprednisolone—multiple sclerosis	0.00118	0.00195	CcSEcCtD
Amifostine—Convulsion—Methotrexate—multiple sclerosis	0.00117	0.00194	CcSEcCtD
Amifostine—Chest pain—Methotrexate—multiple sclerosis	0.00115	0.0019	CcSEcCtD
Amifostine—Rash—Prednisolone—multiple sclerosis	0.00115	0.00189	CcSEcCtD
Amifostine—Dermatitis—Prednisolone—multiple sclerosis	0.00115	0.00189	CcSEcCtD
Amifostine—Discomfort—Methotrexate—multiple sclerosis	0.00114	0.00188	CcSEcCtD
Amifostine—Dizziness—Triamcinolone—multiple sclerosis	0.00111	0.00183	CcSEcCtD
Amifostine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.0011	0.00183	CcSEcCtD
Amifostine—Dizziness—Methylprednisolone—multiple sclerosis	0.0011	0.00182	CcSEcCtD
Amifostine—Feeling abnormal—Prednisone—multiple sclerosis	0.00109	0.0018	CcSEcCtD
Amifostine—Nausea—Prednisolone—multiple sclerosis	0.00108	0.00179	CcSEcCtD
Amifostine—Pruritus—Betamethasone—multiple sclerosis	0.00107	0.00177	CcSEcCtD
Amifostine—Pruritus—Dexamethasone—multiple sclerosis	0.00107	0.00177	CcSEcCtD
Amifostine—Vomiting—Triamcinolone—multiple sclerosis	0.00106	0.00176	CcSEcCtD
Amifostine—Vomiting—Methylprednisolone—multiple sclerosis	0.00106	0.00175	CcSEcCtD
Amifostine—Rash—Triamcinolone—multiple sclerosis	0.00105	0.00174	CcSEcCtD
Amifostine—Dermatitis—Triamcinolone—multiple sclerosis	0.00105	0.00174	CcSEcCtD
Amifostine—Rash—Methylprednisolone—multiple sclerosis	0.00105	0.00174	CcSEcCtD
Amifostine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00105	0.00174	CcSEcCtD
Amifostine—Urticaria—Prednisone—multiple sclerosis	0.00105	0.00173	CcSEcCtD
Amifostine—Body temperature increased—Prednisone—multiple sclerosis	0.00104	0.00173	CcSEcCtD
Amifostine—Hypotension—Methotrexate—multiple sclerosis	0.00103	0.00171	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—SPP1—multiple sclerosis	0.00102	0.0526	CbGpPWpGaD
Amifostine—Dizziness—Dexamethasone—multiple sclerosis	0.001	0.00166	CcSEcCtD
Amifostine—Dizziness—Betamethasone—multiple sclerosis	0.001	0.00166	CcSEcCtD
Amifostine—Nausea—Triamcinolone—multiple sclerosis	0.000993	0.00164	CcSEcCtD
Amifostine—Nausea—Methylprednisolone—multiple sclerosis	0.000991	0.00164	CcSEcCtD
Amifostine—Dyspnoea—Methotrexate—multiple sclerosis	0.000984	0.00163	CcSEcCtD
Amifostine—Somnolence—Methotrexate—multiple sclerosis	0.000982	0.00162	CcSEcCtD
Amifostine—Hypersensitivity—Prednisone—multiple sclerosis	0.000973	0.00161	CcSEcCtD
Amifostine—Vomiting—Betamethasone—multiple sclerosis	0.000965	0.00159	CcSEcCtD
Amifostine—Vomiting—Dexamethasone—multiple sclerosis	0.000965	0.00159	CcSEcCtD
Amifostine—Rash—Dexamethasone—multiple sclerosis	0.000957	0.00158	CcSEcCtD
Amifostine—Rash—Betamethasone—multiple sclerosis	0.000957	0.00158	CcSEcCtD
Amifostine—Dermatitis—Dexamethasone—multiple sclerosis	0.000956	0.00158	CcSEcCtD
Amifostine—Dermatitis—Betamethasone—multiple sclerosis	0.000956	0.00158	CcSEcCtD
Amifostine—Pruritus—Prednisone—multiple sclerosis	0.000935	0.00155	CcSEcCtD
Amifostine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00091	0.0015	CcSEcCtD
Amifostine—Nausea—Betamethasone—multiple sclerosis	0.000901	0.00149	CcSEcCtD
Amifostine—Nausea—Dexamethasone—multiple sclerosis	0.000901	0.00149	CcSEcCtD
Amifostine—Urticaria—Methotrexate—multiple sclerosis	0.000877	0.00145	CcSEcCtD
Amifostine—Dizziness—Prednisone—multiple sclerosis	0.000874	0.00144	CcSEcCtD
Amifostine—Body temperature increased—Methotrexate—multiple sclerosis	0.000873	0.00144	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—CNR1—multiple sclerosis	0.000871	0.045	CbGpPWpGaD
Amifostine—Vomiting—Prednisone—multiple sclerosis	0.00084	0.00139	CcSEcCtD
Amifostine—Rash—Prednisone—multiple sclerosis	0.000833	0.00138	CcSEcCtD
Amifostine—Dermatitis—Prednisone—multiple sclerosis	0.000832	0.00138	CcSEcCtD
Amifostine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000813	0.00134	CcSEcCtD
Amifostine—Nausea—Prednisone—multiple sclerosis	0.000785	0.0013	CcSEcCtD
Amifostine—Pruritus—Methotrexate—multiple sclerosis	0.000781	0.00129	CcSEcCtD
Amifostine—Dizziness—Methotrexate—multiple sclerosis	0.00073	0.00121	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—BDNF—multiple sclerosis	0.000704	0.0364	CbGpPWpGaD
Amifostine—Vomiting—Methotrexate—multiple sclerosis	0.000702	0.00116	CcSEcCtD
Amifostine—Rash—Methotrexate—multiple sclerosis	0.000696	0.00115	CcSEcCtD
Amifostine—Dermatitis—Methotrexate—multiple sclerosis	0.000696	0.00115	CcSEcCtD
Amifostine—Nausea—Methotrexate—multiple sclerosis	0.000656	0.00108	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—MMP9—multiple sclerosis	0.000636	0.0329	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—SPP1—multiple sclerosis	0.000625	0.0323	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—multiple sclerosis	0.00062	0.0321	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—multiple sclerosis	0.000552	0.0285	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—MMP9—multiple sclerosis	0.000541	0.028	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—TGFB1—multiple sclerosis	0.000524	0.0271	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK1—multiple sclerosis	0.000502	0.0259	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—multiple sclerosis	0.000446	0.023	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SRM—multiple sclerosis	0.000378	0.0195	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT3—multiple sclerosis	0.000296	0.0153	CbGpPWpGaD
Amifostine—ENPP1—Disease—GPC5—multiple sclerosis	0.000291	0.015	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000269	0.0139	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP27B1—multiple sclerosis	0.000266	0.0138	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP24A1—multiple sclerosis	0.000266	0.0138	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPC5—multiple sclerosis	0.000244	0.0126	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAPK1—multiple sclerosis	0.00021	0.0109	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—RRM1—multiple sclerosis	0.000202	0.0104	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPL5—multiple sclerosis	0.000189	0.00978	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC11A1—multiple sclerosis	0.000181	0.00937	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD28—multiple sclerosis	0.000145	0.00748	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—BCHE—multiple sclerosis	0.000116	0.006	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD86—multiple sclerosis	0.000103	0.00534	CbGpPWpGaD
Amifostine—ENPP1—Disease—CCR5—multiple sclerosis	9.16e-05	0.00473	CbGpPWpGaD
Amifostine—ENPP1—Disease—HLA-A—multiple sclerosis	8.92e-05	0.00461	CbGpPWpGaD
Amifostine—ENPP1—Disease—APOE—multiple sclerosis	8.33e-05	0.00431	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD80—multiple sclerosis	7.53e-05	0.00389	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—APOE—multiple sclerosis	6.98e-05	0.00361	CbGpPWpGaD
Amifostine—ENPP1—Disease—TYK2—multiple sclerosis	6.36e-05	0.00329	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—POMC—multiple sclerosis	5.99e-05	0.0031	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD4—multiple sclerosis	5.75e-05	0.00297	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALB—multiple sclerosis	5.46e-05	0.00282	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT3—multiple sclerosis	4.45e-05	0.0023	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—multiple sclerosis	4.14e-05	0.00214	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—multiple sclerosis	4.13e-05	0.00213	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK1—multiple sclerosis	4.05e-05	0.00209	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—multiple sclerosis	3.11e-05	0.00161	CbGpPWpGaD
